Main groups of proprotein convertase subtilisin/kexin type 9 inhibitors: mechanisms of action and clinical efficacy. Part 1
2007 ◽
Vol 1117
(1)
◽
pp. 209-257
◽
2013 ◽
Vol 30
(2)
◽
pp. 72-79
◽
2004 ◽
Vol 6
(2)
◽
pp. 148-157
◽
2018 ◽
Vol 827
◽
pp. 103-111
◽
Keyword(s):